Zhu, Ming-Huan
Liu, Zhen-Jing
Hu, Qiong-Yue
Yang, Jia-Yu
Jin, Ying
Zhu, Na
Huang, Ying
Shi, Dian-Hong
Liu, Min-Jia
Tan, Hong-Yang
Zhao, Lei
Lv, Qin-Yu
Yi, Zheng-Hui
Wu, Feng-Chun
Li, Ze-Zhi
Clinical trials referenced in this document:
Documents that mention this clinical trial
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
https://doi.org/10.1186/s40779-022-00420-0
Funding for this research was provided by:
Clinical Research Project of Shanghai Municipal Health (20204Y0173)
the National Natural Science Foundation of China (81401127)
Scientific research project of traditional Chinese medicine of Guangdong (20192070)
Science and Technology Plan Project of Guangdong Province (2019B030316001)
Guangzhou municipal key discipline in medicine (2021-2023)
State Key Laboratory of Control and Simulation of Power System and Generation Equipment (VRLAB2022 B02)
Shanghai Key Laboratory of Psychotic Disorders Open Grant (21-K03)
Article History
Received: 28 December 2021
Accepted: 19 September 2022
First Online: 18 October 2022
Declarations
:
: Regulatory approvals for this study were obtained from the Institutional Review Board of Shanghai Pudong New Area Mental Health Center (No. 2018008). All participants gave their informed consent before their inclusion in the study.
: Not applicable.
: The authors declare that they have no competing interests.